Ron‐Patrick Cadeddu

498 total citations
19 papers, 253 citations indexed

About

Ron‐Patrick Cadeddu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Ron‐Patrick Cadeddu has authored 19 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Ron‐Patrick Cadeddu's work include Acute Myeloid Leukemia Research (5 papers), Mesenchymal stem cell research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Ron‐Patrick Cadeddu is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Mesenchymal stem cell research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Ron‐Patrick Cadeddu collaborates with scholars based in Germany, United States and France. Ron‐Patrick Cadeddu's co-authors include Rainer Haas, T. Heinzel, M. Luysberg, Ingmar Bruns, Julia Fröbel, Lisa Zimmermann, C. Matthias Wilk, Christoph Janiak, Akos Czibere and Thomas Schroeder and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Cancer.

In The Last Decade

Ron‐Patrick Cadeddu

16 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron‐Patrick Cadeddu Germany 10 85 80 64 58 35 19 253
Yanan Pi China 8 85 1.0× 191 2.4× 51 0.8× 21 0.4× 63 1.8× 13 357
Zdeněk Škrott Czechia 10 22 0.3× 169 2.1× 42 0.7× 22 0.4× 103 2.9× 15 360
Neha Singh United States 12 21 0.2× 178 2.2× 34 0.5× 25 0.4× 83 2.4× 21 355
Molly Y. Mollica United States 6 16 0.2× 166 2.1× 95 1.5× 28 0.5× 28 0.8× 17 351
Carrie Batt United States 9 108 1.3× 103 1.3× 152 2.4× 38 0.7× 28 0.8× 13 351
C. Belcher United Kingdom 6 56 0.7× 76 0.9× 18 0.3× 24 0.4× 17 0.5× 7 353
Miaoling He United States 11 30 0.4× 157 2.0× 56 0.9× 14 0.2× 99 2.8× 20 384
Paola Faraoni Italy 11 45 0.5× 217 2.7× 33 0.5× 9 0.2× 72 2.1× 27 403
Kristýna Pimková Czechia 11 13 0.2× 213 2.7× 86 1.3× 32 0.6× 11 0.3× 18 354
Li Tan China 13 38 0.4× 259 3.2× 43 0.7× 31 0.5× 36 1.0× 21 433

Countries citing papers authored by Ron‐Patrick Cadeddu

Since Specialization
Citations

This map shows the geographic impact of Ron‐Patrick Cadeddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron‐Patrick Cadeddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron‐Patrick Cadeddu more than expected).

Fields of papers citing papers by Ron‐Patrick Cadeddu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron‐Patrick Cadeddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron‐Patrick Cadeddu. The network helps show where Ron‐Patrick Cadeddu may publish in the future.

Co-authorship network of co-authors of Ron‐Patrick Cadeddu

This figure shows the co-authorship network connecting the top 25 collaborators of Ron‐Patrick Cadeddu. A scholar is included among the top collaborators of Ron‐Patrick Cadeddu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron‐Patrick Cadeddu. Ron‐Patrick Cadeddu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Zhixin, Tatsiana Suvorava, Ron‐Patrick Cadeddu, et al.. (2025). Divergent roles of red cell arginase in humans and mice: RBC Arg1 KO mice show preserved systemic l-arginine bioavailability and infarct size in vivo. Redox Biology. 86. 103768–103768.
2.
3.
Schroeder, Thomas, Matthias Stelljes, Maximilian Christopeit, et al.. (2023). Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial. Haematologica. 108(11). 3001–3010. 10 indexed citations
4.
5.
Cadeddu, Ron‐Patrick, et al.. (2020). Impaired Formation of Neutrophil Extracellular Traps (NETs) in Patients with Myelodysplastic Syndrome (MDS). Blood. 136(Supplement 1). 5–6. 9 indexed citations
6.
Zimmermann, Lisa, Ron‐Patrick Cadeddu, M. Luysberg, et al.. (2019). The Low Toxicity of Graphene Quantum Dots is Reflected by Marginal Gene Expression Changes of Primary Human Hematopoietic Stem Cells. Scientific Reports. 9(1). 12028–12028. 62 indexed citations
7.
8.
Cadeddu, Ron‐Patrick, Katharina Raba, Johannes Fischer, et al.. (2017). Uptake dynamics of graphene quantum dots into primary human blood cells following in vitro exposure. RSC Advances. 7(20). 12208–12216. 29 indexed citations
9.
Wilk, C. Matthias, Ron‐Patrick Cadeddu, Ariane Dienst, et al.. (2016). Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis. International Journal of Cancer. 139(10). 2343–2352. 1 indexed citations
10.
Cadeddu, Ron‐Patrick, et al.. (2015). Influence of Di(2-ethylhexyl)phthalate on migration rate and differentiation of human hematopoietic stem and progenitor cells (CD34+). Clinical Hemorheology and Microcirculation. 61(2). 111–118. 5 indexed citations
11.
Cadeddu, Ron‐Patrick, et al.. (2014). Impact of Di(2-ethylhexyl)phthalate on migration rate of human promyelocytic leukemia cells (HL-60). Clinical Hemorheology and Microcirculation. 58(1). 241–246. 4 indexed citations
12.
Fröbel, Julia, Ron‐Patrick Cadeddu, Sonja Hartwig, et al.. (2013). Platelet Proteome Analysis Reveals Integrin-dependent Aggregation Defects in Patients with Myelodysplastic Syndromes. Molecular & Cellular Proteomics. 12(5). 1272–1280. 30 indexed citations
13.
Wilk, C. Matthias, Frank A. Schildberg, Marcel A. Lauterbach, et al.. (2013). The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells. Experimental Hematology. 41(9). 823–831.e2. 16 indexed citations
14.
Schroeder, Thomas, Julia Fröbel, Ron‐Patrick Cadeddu, et al.. (2012). Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation. Blood. 120(21). 1964–1964. 1 indexed citations
15.
Singh, Raminder, Julia Fröbel, Ron‐Patrick Cadeddu, et al.. (2011). The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells. Annals of Hematology. 91(2). 173–181. 1 indexed citations
16.
Singh, Raminder, Ron‐Patrick Cadeddu, Julia Fröbel, et al.. (2011). The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway. APOPTOSIS. 16(9). 889–901. 39 indexed citations
17.
Geyh, Stefanie, Ron‐Patrick Cadeddu, Julia Fröbel, et al.. (2011). Analysis of Mesenchymal Stromal Cells (MSC) and Their Interactions with CD34 Stem and Progenitor Cells in Patients with Myelodysplastic Syndromes (MDS). Blood. 118(21). 2393–2393.
18.
Schmelzle, Moritz, Levent Dizdar, Hanno Matthaei, et al.. (2010). Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9). Prostaglandins & Other Lipid Mediators. 94(1-2). 25–33. 24 indexed citations
19.
Wilk, C. Matthias, Akos Czibere, Ron‐Patrick Cadeddu, et al.. (2009). TIMP–1 Plays a Functional Role in CD34. + Hematopoietic Stem and Progenitor Cells.. Blood. 114(22). 1487–1487.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanan Pi Breakdown of academic impact, for papers by Zdeněk Škrott Breakdown of academic impact, for papers by Neha Singh Breakdown of academic impact, for papers by Molly Y. Mollica Breakdown of academic impact, for papers by Carrie Batt Breakdown of academic impact, for papers by C. Belcher Breakdown of academic impact, for papers by Miaoling He Breakdown of academic impact, for papers by Paola Faraoni Breakdown of academic impact, for papers by Kristýna Pimková Breakdown of academic impact, for papers by Li Tan
Rankless by CCL
2026